Indianapolis, INNCT05844501Now EnrollingIRB Ready

Atrial Fibrillation Clinical Trial in Indianapolis, IN

Access cutting-edge atrial fibrillation treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Indiana University

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions...

Expert Care in Indianapolis

Access atrial fibrillation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atrial fibrillation treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this atrial fibrillation clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Atrial Fibrillation Study in Indianapolis

"Afib" is a common irregular heartbeat. Afib can cause stroke, blood clots, dementia and death. Medicines used to treat Afib often do not work well and can cause serious side effects. Clinicians need medicines that work better for Afib. Medicines for Afib work by blocking a current in the heart called a potassium current. There is a newer potassium current called IKas that can contribute to Afib. A medicine called ondansetron is used to keep people with cancer from getting sick to their stomach

Sponsor: Indiana University

Who Can Participate

Inclusion Criteria

Men and women 18-100 years of age
ECG-verified AF and/or atrial flutter requiring elective catheter ablation
Receiving guideline-recommended anticoagulation (if CHA2DS2-VASc score is 0 (men) or 1 (women), anticoagulation can be omitted)

Exclusion Criteria

Women of childbearing potential
Subject reported syncope of unknown origin within the previous 6 months
Diagnosis of active thyrotoxicosis
Diagnosis AF from reversible noncardiac causes
Diagnosis of acutely decompensated heart failure
Left ventricular ejection fraction less than or equal to 20%
New York Heart Association class IV heart failure
Diagnosis of severe liver disease (Child-Pugh score greater than or equal to 10)
Cardiac surgery (preceding 2 months)
Not receiving anticoagulation due to contraindications (as determined by treating physician and recorded in the medical record)
Pretreatment QRS \> 180 ms, QTc \> 450 ms within two weeks of screening visit
Heart rate \< 5

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT05844501) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atrial Fibrillation Treatment Options in Indianapolis, IN

If you're searching for atrial fibrillation treatment options in Indianapolis, IN, this clinical trial (NCT05844501) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all atrial fibrillation clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Indianapolis, IN

See all atrial fibrillation clinical trials recruiting in Indianapolis — not just this study.

Browse Atrial Fibrillation Trials in Indianapolis

Browse More Trials by Condition

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN